Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/03/2002US20020142317 Methods for the early diagnosis of ovarian cancer
10/03/2002US20020142303 Diagnosing schizophrenia in humans; obtain bodily fluid, electrophoresis, detect protein isoform, compare to control, evaluate for schizophrenia
10/03/2002US20020142302 Novel nucleic acids and polypeptides
10/03/2002US20020142298 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/03/2002US20020142292 Mammalian genes; related reagents and methods
10/03/2002US20020142049 Precipitating drug as solid
10/03/2002US20020142047 Microsphere delivery of mucin peptides
10/03/2002US20020142010 Administering neurotoxin
10/03/2002US20020142004 Immunoreactive and immunotherapeutic molecules
10/03/2002US20020142003 Tumor-associated antigen (B345)
10/03/2002US20020142000 Genetic engineering
10/03/2002US20020141999 Complexing; immunoassay, immunotherapy
10/03/2002US20020141996 Methods of treating infections with chimeric anti-TNF antibodies
10/03/2002US20020141995 Using transforming growth factor
10/03/2002US20020141993 Apoptosis; anticancer agents
10/03/2002US20020141990 Genetic engineering; neutralizing infections
10/03/2002US20020141988 Therapeutic agent for acute lung injury resulting from indirect causes comprising anti-il-8 antibody as active ingredient
10/03/2002US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002US20020141986 Administering protein
10/03/2002US20020141985 Dietetics, eating disorders, antidiabetic agents
10/03/2002US20020141983 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
10/03/2002US20020141982 Gene therapy methods using bone marrow-derived cells
10/03/2002US20020141981 Materials and methods for treating oncological disease
10/03/2002US20020141980 Convection-enhanced delivery of AAV vectors
10/03/2002US20020141972 Administering protein and antiinflection agent
10/03/2002US20020141971 Administering by tissue absorption
10/03/2002US20020141970 Stabilized with chelate compound; storage stability
10/03/2002US20020141946 Formulation of dipalmitoylphosphatidyl choline (DPPC), insulin and sodium citrate
10/03/2002US20020141945 Characteristic glass transition temperature (Tg) and a recommended storage temperature (Ts), glassy matrix and drug within the glassy matrix; unit dosage; stable dispersion over time
10/03/2002US20020141941 PSCA: prostate stem cell antigen and uses thereof
10/03/2002CA2664797A1 Cytotoxic factors for modulating cell death
10/03/2002CA2452233A1 Method of inducing proliferation of retinal stem cells
10/03/2002CA2445640A1 Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms)
10/03/2002CA2442797A1 Human secreted proteins
10/03/2002CA2442777A1 Human secreted proteins
10/03/2002CA2442610A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/03/2002CA2442325A1 Shellfish protein
10/03/2002CA2442318A1 Antibodies against cancer
10/03/2002CA2442077A1 Novel nucleic acids and polypeptides
10/03/2002CA2442015A1 Anthrax lethal factor inhibits tumor growth and angiogenesis
10/03/2002CA2442004A1 Microbial feeds for aquaculture and agriculture
10/03/2002CA2442003A1 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002CA2441986A1 Methods and products related to fgf dimerization
10/03/2002CA2441936A1 Methods and compositions for modulating tumor suppression
10/03/2002CA2441889A1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002CA2441704A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/03/2002CA2441703A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441684A1 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
10/03/2002CA2441670A1 Novel nucleic acids and polypeptides
10/03/2002CA2441661A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/03/2002CA2441649A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/03/2002CA2441588A1 Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders
10/03/2002CA2441580A1 Coagulation factor vii derivatives
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441484A1 Molecular conjugates for use in treatment of cancer
10/03/2002CA2441413A1 Human secreted proteins
10/03/2002CA2441403A1 Novel agents for ameliorating motor disorder
10/03/2002CA2441397A1 Human secreted proteins
10/03/2002CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
10/03/2002CA2441227A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002CA2441201A1 Thrombin and anhydrothrombin with modified carboxyl groups
10/03/2002CA2440582A1 Serum albumin binding moieties
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002CA2439409A1 Inhibitors of glycosaminoglycans
10/03/2002CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2436224A1 Cytotoxic factors for modulating cell death
10/03/2002CA2434119A1 Method of preventing t cell-mediated responses by the use of the major histocompatibility complex class ii analog protein (map protein) from staphylococcus aureus
10/03/2002CA2433458A1 Keratinocyte growth factor-2
10/03/2002CA2425862A1 Cd19-specific redirected immune cells
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/02/2002EP1245681A2 A method for the production of pharmaceutically active recombinant proteins comprising the use of alkanoic acids, their derivatives or salts thereof
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/02/2002EP1245675A1 Cancer cell-specific HLA-F antigen and a diagnostic method of cancer by using thereof
10/02/2002EP1245580A1 Fibre containing composition for enteral nutrition
10/02/2002EP1245574A1 14691, A human glutamate receptor family member and uses therefor
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002EP1245237A1 Treatment of skin conditions
10/02/2002EP1245236A1 Preventives and remedies for chronic hepatitis
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1245222A2 Topical composition containing fibres and enzymes
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244805A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes
10/02/2002EP1244804A1 Inhibition of cellular proteases
10/02/2002EP1244796A2 Transduction of recombinases for inducible gene targeting
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244786A1 Screening method for compounds capable of modularing egr-1-regulated expression
10/02/2002EP1244785A1 Mus101 and homologues thereof
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244783A1 Improving stability of flint through o-linked glycosylation
10/02/2002EP1244781A2 Antisense oligonucleotides
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244778A2 Human heparanase-related polypeptide and nucleic acid
1 ... 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 ... 3163